Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India. - Wikidata - wikimedia - TriplyDB

Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India.

Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India.

http://www.wikidata.org/entity/Q33441582

about

Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India.

http://www.wikidata.org/entity/Q33441582

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Taxane Combination Chemotherap ...... rtiary Cancer Centre in India.

@ast

Taxane Combination Chemotherap ...... rtiary Cancer Centre in India.

@en

type

label

Taxane Combination Chemotherap ...... rtiary Cancer Centre in India.

@ast

Taxane Combination Chemotherap ...... rtiary Cancer Centre in India.

@en

prefLabel

Taxane Combination Chemotherap ...... rtiary Cancer Centre in India.

@ast

Taxane Combination Chemotherap ...... rtiary Cancer Centre in India.

@en

P1433

Q33441582-E262D09E-57D3-4A50-82E5-8591BD50C3E7

P1476

Q33441582-3181479B-C8F6-46F2-B416-BF2E75D30511

P2093

Q33441582-15C16375-E2F6-4350-88D6-53F8320FA396

Q33441582-1DB2EA0C-9CDE-40AB-AFA0-521D1A8A0C98

Q33441582-327C32E3-3797-4E09-B6F3-8707EC680E3B

Q33441582-37436930-234C-4DF5-9019-8110835C0187

Q33441582-50B9CC97-FA37-49EA-AE21-671BD729424E

Q33441582-914F0F13-FDB8-4AE8-A734-439EE2EE8A66

Q33441582-9ED8033F-C5C1-433F-9D82-D3387D6821DE

P2860

Q33441582-06FFB312-6A53-4294-9448-20F779497684

Q33441582-1799C6A6-471A-40E8-83C7-0A476DB2CBD8

Q33441582-38F9A894-6BA1-407D-A149-437F3030591F

Q33441582-5EB1B854-4E03-49AF-AC12-F1BC0A1D2ECD

Q33441582-720754C8-4CD6-4FA4-A6FA-5A4B4E04AAC4

Q33441582-765A2865-B603-4E64-9A3A-2F8E1331CF08

Q33441582-7A10523F-7867-4964-810F-9A3490926E75

Q33441582-812AE48F-1BE7-4CB2-84DE-90774D83FCD7

Q33441582-8577DE62-11CE-40DB-AFBF-C8962B881628

Q33441582-98ACA5D4-2A6C-4B6A-9D56-3BEB2202A997

P304

Q33441582-C82C482A-9E46-4B74-8443-51D351F08CA9

P31

Q33441582-1DA5F5BE-DAFF-4C1E-9BF8-81F7A0BF8ECE

P356

Q33441582-CC015E3D-1139-41CA-8C0F-5537E18DBC0A

P433

Q33441582-621E4E9E-AF6A-4FF3-9AF2-8B870A21B76D

P478

Q33441582-1265CF6D-3832-4A72-B667-6895A397D16D

P577

Q33441582-E622FC56-3BF7-4324-8396-F1A186ABF25E

P698

Q33441582-DCDF5C0E-5E05-4382-89F2-8ADA21C91227

P932

Q33441582-D3B9FC46-877B-48AB-A58A-503404E0C505

P356

0971-5851.203498

P1433

Indian Journal of Medical and Paediatric Oncology

P1476

Taxane Combination Chemotherap ...... rtiary Cancer Centre in India.

@en

P2093

Deepa Susan

http://www.w3.org/2001/XMLSchema#string

Jaya Ghosh

http://www.w3.org/2001/XMLSchema#string

Jyoti Bajpai

http://www.w3.org/2001/XMLSchema#string

R A Badwe

http://www.w3.org/2001/XMLSchema#string

Reena Nair

http://www.w3.org/2001/XMLSchema#string

Sudeep Gupta

http://www.w3.org/2001/XMLSchema#string

Vijay Patil

http://www.w3.org/2001/XMLSchema#string

P2860

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

Breast Cancer Care in India: The Current Scenario and the Challenges for the Future.

Is breast cancer the same disease in Asian and Western countries?

Taxanes in adjuvant breast cancer setting: which standard in Europe?

Pharmacogenetics in breast cancer therapy.

Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colo

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.

Adjuvant docetaxel for node-positive breast cancer.

P304

18-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0971-5851.203498

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28469332

http://www.w3.org/2001/XMLSchema#string

P932

5398100

http://www.w3.org/2001/XMLSchema#string